Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.729
+0.029 (1.06%)
Apr 25, 2025, 12:19 PM EDT - Market open
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $87.84 million as of April 25, 2025. Its market cap has decreased by -15.29% in one year.
Market Cap
87.84M
Enterprise Value
69.90M
1-Year Change
-15.29%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $87.84M, an increase of 5.58%. That is a compound annual growth rate of 0.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2025 | 86.90M | 16.33% |
Dec 31, 2024 | 74.70M | -38.06% |
Dec 29, 2023 | 120.60M | -7.44% |
Dec 30, 2022 | 130.30M | 46.40% |
Dec 31, 2021 | 89.00M | 21.92% |
Dec 31, 2020 | 73.00M | 10.11% |
Dec 31, 2019 | 66.30M | -10.04% |
Dec 31, 2018 | 73.70M | 106.44% |
Dec 29, 2017 | 35.70M | -24.52% |
Dec 30, 2016 | 47.30M | 79.85% |
Dec 31, 2015 | 26.30M | 10.04% |
Dec 31, 2014 | 23.90M | -39.34% |
Dec 31, 2013 | 39.40M | 18.32% |
Dec 31, 2012 | 33.30M | 73.44% |
Dec 30, 2011 | 19.20M | -39.81% |
Dec 31, 2010 | 31.90M | -65.14% |
Dec 31, 2009 | 91.50M | 61.95% |
Dec 31, 2008 | 56.50M | -63.00% |
Dec 31, 2007 | 152.70M | 62.27% |
Dec 29, 2006 | 94.10M | 31.24% |
Dec 30, 2005 | 71.70M | -0.42% |
Dec 31, 2004 | 72.00M | 94.07% |
Dec 31, 2003 | 37.10M | 183.21% |
Dec 31, 2002 | 13.10M | -52.88% |
Dec 31, 2001 | 27.80M | -35.94% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 735.92B |
UnitedHealth Group | 388.88B |
Johnson & Johnson | 380.51B |
AbbVie | 306.62B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 227.73B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |